InChI=1S/C17H17Cl2N/c1- 20- 17- 9- 7- 12(13- 4- 2- 3- 5- 14(13) 17) 11- 6- 8- 15(18) 16(19) 10- 11/h2- 6,8,10,12,17,20H,7,9H2,1H3/t12- ,17- /m0/s1 |
VGKDLMBJGBXTGI-SJCJKPOMSA-N |
[H][C@]1(CC[C@H](NC)c2ccccc12)c1ccc(Cl)c(Cl)c1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
serotonin uptake inhibitor
A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.
|
|
serotonin uptake inhibitor
A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
|
|
View more via ChEBI Ontology
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
|
sertralina
|
ChemIDplus
|
sertraline
|
ChemIDplus
|
sertralinum
|
ChemIDplus
|
(+)-sertraline
|
ChEBI
|
(1S,4S)-sertraline
|
ChemIDplus
|
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
|
ChemIDplus
|
cis-(+)-sertraline
|
ChEBI
|
CP 51974
|
NIST Chemistry WebBook
|
Sertraline
|
KEGG COMPOUND
|
2436
|
DrugCentral
|
C07246
|
KEGG COMPOUND
|
D02360
|
KEGG DRUG
|
DB01104
|
DrugBank
|
HMDB0005010
|
HMDB
|
LSM-3843
|
LINCS
|
Sertraline
|
Wikipedia
|
SRE
|
PDBeChem
|
US4536518
|
Patent
|
View more database links |
5753709
|
Reaxys Registry Number
|
Reaxys
|
79617-96-2
|
CAS Registry Number
|
ChemIDplus
|
79617-96-2
|
CAS Registry Number
|
NIST Chemistry WebBook
|
19502000
|
PubMed citation
|
Europe PMC
|
21823671
|
PubMed citation
|
Europe PMC
|
|